Paloma Bragado

Featured publications

• Differential expression of neurogenes among breast cancer subtypes identifies high risk patients

  Authors:

  Fernandez-Nogueira, Patricia; Bragado, Paloma; Almendro, Vanessa; Ametller, Elisabet; Rios, Jose;

  Choudhury, Sibgat; Mancino, Mario; Gascon, Pedro;.

  Reference: ONCOTARGET.

• The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase

  Authors:

  Erazo, Tatiana; Lorente, Mar; Lopez-Plana, Anna; Munoz-Guardiola, Pau; Fernandez-Nogueira, Patricia;

  (...)

  Gomez-Ferreria, Mariana; Alfon, Jose; Velasco, Guillermo; Domenech, Carles; Lizcano, Jose M.;.

  See complete list of authors

  Reference: CLINICAL CANCER RESEARCH.

• C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38alpha activation, while it impairs tumor growth through p38alpha-independent mechanisms

  Authors:

  Priego, N; Arechederra, M; Sequera, C; Bragado, P; Vazquez-Carballo, A;

  (...)

  Martin-Granado, V; Ventura, JJ; Kazanietz, MG; Guerrero, C; Porras, A.

  See complete list of authors

  Reference: ONCOTARGET.

• Mechanisms of disseminated cancer cell dormancy: An awakening field

  Authors:

  Sosa, MS; Bragado, P; Aguirre-Ghiso, JA;

  Reference: NATURE REVIEWS CANCER.

• p38α MAPK can positively or negatively regulate Rac-1 activity depending on the presence of serum

  Authors:

  Zuluaga S; Gutiérrez-Uzquiza A; Bragado P; Álvarez-Barrientos A; Benito M;

  Nebreda A; Porras A.

  Reference: FEBS LETTERS.

• Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer

  Authors:

  Fernández-Nogueira P.; Noguera-Castells A.; Fuster G.; Recalde-Percaz L.; Moragas N.;

  (...)

  Carbó N.; Almendro V.; Gascón P.; Bragado P.; Mancino M..

  See complete list of authors

  Reference: CANCER LETTERS.